MYCN and neuroblastoma: Aggressive neuroblastomas are further classified based on the presence of the MYCN amplification (appearing in ~16% of patients and associated with the worst prognosis of all subtypes2) and segmental aberrations, such as the loss of chromosome arms 1p and 11q or the gain of chromosome arm 17q2.